PrEP for Transgender and Gender Non-Conforming Individuals
Transgender and gender non-conforming individuals bear a disproportionate burden of HIV in the United States. PrEP is a highly effective HIV prevention strategy and while the data about its safety and efficacy in this population are encouraging, inclusion of transgender persons in clinical trials and demonstration projects have been limited, to date. As we’re scaling up PrEP in communities around the country, several barriers to PrEP use in have been documented as well as promising strategies for engaging gender and sexual minorities.
By the end of this webinar, participants will:
- Review the evidence of safety and efficacy of PrEP in transgender and gender non-conforming populations
- Understand possible barriers and facilitators of PrEP uptake
- Highlight novel efforts to engage the transgender and gender non-conforming communities in discovery and implementation science
We will end with a Question & Answer session along with an overview of how your health department can get free assistance on building capacity in high impact HIV prevention. We encourage everyone to follow along and ask questions on Twitter using the hashtag #PrEPTalkSF.